Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
about
Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD PatientsGut microbial flora, prebiotics, and probiotics in IBD: their current usage and utilityMicrobiota biodiversity in inflammatory bowel diseaseProbiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics.Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.Lactobacillus reuteri I5007 modulates tight junction protein expression in IPEC-J2 cells with LPS stimulation and in newborn piglets under normal conditions.Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?Attenuation of Colitis by Lactobacillus casei BL23 Is Dependent on the Dairy Delivery Matrix.Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative ColitisNew approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-AnalysisA gastroenterologist's guide to probiotics.Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease.Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitisMucosa-reparing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice.Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications.Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in childrenLocal and systemic immune mechanisms underlying the anti-colitis effects of the dairy bacterium Lactobacillus delbrueckii.Long-term use of probiotics Lactobacillus and Bifidobacterium has a prophylactic effect on the occurrence and severity of pouchitis: a randomized prospective studyShould probiotics be tested on ex vivo organ culture models?Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease.The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?Specific probiotics or 'fecal transplantation'.Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis.Microbial activation of gut dendritic cells and the control of mucosal immunity.Four types of Bifidobacteria trigger autophagy response in intestinal epithelial cells.Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study.Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates.Effect of a double-coated probiotic formulation on functional constipation in the elderly: a randomized, double blind, controlled study.Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis.Butyricicoccus pullicaecorum in inflammatory bowel disease.Evidence-based clinical practice guidelines for inflammatory bowel disease.Bifidobacteria Enhance Antigen Sampling and Processing by Dendritic Cells in Pediatric Inflammatory Bowel Disease.
P2860
Q26750985-48B8EBC1-2ADA-4B6F-8B10-66ABD030E218Q26995672-F2D0153E-76B5-439F-AF4F-2F76CF179401Q27027772-8A000FBB-DE5E-489B-995A-30A37E94C650Q29037475-218F21A5-95C8-4179-9B05-3E210F2F3668Q33618653-6682D246-B86F-4821-9FAB-13DD43FF8E5EQ35000008-52012380-B96C-427D-AA0A-8E6609275364Q35150607-52EC7538-6AB3-4CA3-A74A-25F4A68E2D5DQ35558415-30EA9B3C-BA20-4870-89DA-DFD822073AE6Q35688499-60B59552-B850-4F7A-8620-B691C8FB862EQ35750427-DB757766-7748-429B-A69D-AF7E7A896084Q35812927-E296625C-2DB5-47A8-82B4-D2D2E829916DQ36046935-FBFD6547-F2C7-4AD1-A005-E270760EFC48Q36179468-A6385EAE-CE18-4821-A05B-4D1FCE160FD1Q36250322-77E7CF4C-3A0F-48F3-A029-0618B578B327Q37118873-5B43652D-656D-4A6A-AEFC-834B1C7FB2C7Q37288384-EC0FB912-B6B8-4623-AE7F-8DE3DF7CAE90Q37396622-A45153F6-80E6-4316-B532-B03ACED720A4Q37443830-7946A6EE-FBC2-4E5A-B725-621BE3D681ADQ37499814-133B2DEA-BCC4-42C1-A450-E303FA4694EFQ37570919-8BC297FF-C92A-44C1-9844-8FCA9E5C2A1DQ38020017-1BD48C8A-CADA-4E1E-B110-1C2C9F1AC6A2Q38029111-63B55309-5B90-4429-A3D1-3F18EBFC163DQ38049252-417F6163-6C15-41D2-8476-F3927BA83505Q38072229-F88FAF53-EBAB-4773-94AF-12377F9484E1Q38122352-76ADA9CE-D1D2-4323-99AD-B2022121B3D2Q38130307-679FF6E7-8290-4AE7-B182-0A08E215036DQ38966092-51BB4BCC-698D-4A56-84A3-23F36ACE775FQ40458954-20E18483-E379-49DD-B0C7-D59464FAD34CQ41933798-9B1726F1-1890-420B-955A-7E0C2CAAC9ADQ43326998-63B8CA06-08FD-4A35-BDAB-580E62A25A5DQ43661996-925283FD-BF09-4D2E-AF23-4F673A630D60Q49142912-D0B651C4-7AB5-4981-AE33-6A94E8313988Q50079201-EEC3AADA-01A4-42CF-AF6A-1685F9B2E7E0Q53536237-CEAC8851-006D-4D97-BD89-2492D66AA657
P2860
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
@en
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
@nl
type
label
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
@en
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
@nl
prefLabel
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
@en
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
@nl
P921
P1476
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
@en
P2093
Bartolomeus Joannes Meijer
Levinus Albert Dieleman
P304
P356
10.1097/MCG.0B013E31822103F7
P478
P577
2011-11-01T00:00:00Z